1. | | Recruiting | Celecoxib in Preventing Skin Cancer Conditions: basal cell carcinoma of the skin; squamous cell carcinoma of the skin |
2. | | No longer recruiting | Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer Conditions: stage IV breast cancer; recurrent breast cancer |
3. | | Recruiting | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis Conditions: refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; primary systemic amyloidosis |
4. | | Recruiting | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Central Nervous System Cancer Conditions: adult brain tumor; paranasal sinus and nasal cavity cancer; primary central nervous system lymphoma |
5. | | No longer recruiting | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer |
6. | | Recruiting | Combination Chemotherapy Followed by Donor Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer or Genetic Disorders Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; plasma cell neoplasm |
7. | | Suspended | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Acute Leukemia Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute lymphoblastic leukemia; childhood acute myeloid leukemia; ... |
8. | | No longer recruiting | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia Conditions: relapsing chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia |
9. | | Recruiting | Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer Conditions: adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer |
10. | | No longer recruiting | Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer Conditions: stage IIIB breast cancer; stage IIIA breast cancer; stage II breast cancer |
11. | | No longer recruiting | CP4071 in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma Conditions: stage IVB adult soft tissue sarcoma; recurrent adult soft tissue sarcoma; stage IVA adult soft tissue sarcoma; stage III adult soft tissue sarcoma |
12. | | No longer recruiting | Docetaxel Combined With Estramustine in Treating Patients With Metastatic Breast Cancer Conditions: stage IV breast cancer; recurrent breast cancer |
13. | | No longer recruiting | Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Conditions: Endometrial Cancer; Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer |
14. | | No longer recruiting | Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer Conditions: adenocarcinoma of the prostate; Quality of Life; stage IV prostate cancer; recurrent prostate cancer |
15. | | Recruiting | Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer Conditions: stage II pancreatic cancer; stage III pancreatic cancer; stage IV pancreatic cancer; Nutrition; adenocarcinoma of the pancreas |
16. | | Completed | Gemcitabine Plus Carboplatin or Cisplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer Conditions: stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer |
17. | | No longer recruiting | High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung Cancer Conditions: extensive stage small cell lung cancer; limited stage small cell lung cancer; stage IIIA non-small cell lung cancer; ... |
18. | | No longer recruiting | Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer Conditions: stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate |
19. | | No longer recruiting | Interferon alfa and Thalidomide in Treating Patients With Soft Tissue Sarcoma or Bone Sarcoma Conditions: stage III adult soft tissue sarcoma; stage IVB adult soft tissue sarcoma; stage IVA adult soft tissue sarcoma; stage IIC adult soft tissue sarcoma; ... |
20. | | No longer recruiting | Irinotecan in Treating Patients With Stage IV or Recurrent Soft Tissue Sarcoma Conditions: stage IVB adult soft tissue sarcoma; recurrent adult soft tissue sarcoma; stage IVA adult soft tissue sarcoma; stage IV adult soft tissue sarcoma |
21. | | Recruiting | Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer Conditions: Langerhans cell histiocytosis; childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; hematopoietic and lymphoid cancer |
22. | | Recruiting | Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving Chemotherapy Conditions: Drug Toxicity; childhood acute lymphoblastic leukemia |
23. | | Recruiting | Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Primary Light Chain Amyloidosis Condition: Amyloidosis |
24. | | No longer recruiting | Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer Conditions: localized malignant mesothelioma; advanced malignant mesothelioma; recurrent malignant mesothelioma |
25. | | Recruiting | Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma Conditions: adult soft tissue sarcoma; uterine leiomyosarcoma; uterine sarcoma |
26. | | No longer recruiting | Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma Conditions: cellular diagnosis, adult soft tissue sarcoma; cellular diagnosis, uterine sarcoma; Cancer; stage, adult soft tissue sarcoma; ... |
27. | | No longer recruiting | Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma Conditions: recurrent adult brain tumor; adult anaplastic oligodendroglioma; adult anaplastic astrocytoma |
28. | | Recruiting | Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Malignant Glioma Conditions: adult brain tumor; childhood brain tumor; childhood cerebellar astrocytoma; childhood cerebral astrocytoma and malignant glioma; childhood ependymoma; ... |
29. | | No longer recruiting | Topotecan and Paclitaxel in Treating Patients With Recurrent or Metastatic Cancer of the Cervix Conditions: recurrent cervical cancer; stage IVB cervical cancer; stage IVA cervical cancer; cervical squamous cell carcinoma; cervical adenocarcinoma |
30. | | Recruiting | Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia Conditions: Langerhans cell histiocytosis; childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; hematopoietic and lymphoid cancer |
31. | | No longer recruiting | Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer Conditions: stage IV colon cancer; Stage IV rectal cancer; adenocarcinoma of the colon; adenocarcinoma of the rectum |
32. | | No longer recruiting | Vaccine Therapy and Sargramostim in Treating Patients With Soft Tissue Sarcoma Conditions: adult soft tissue sarcoma; adult synovial sarcoma |
33. | | No longer recruiting | Vaccine Therapy in Treating Patients With Metastatic Melanoma Conditions: Stage IV Melanoma; Recurrent Melanoma |
34. | | Recruiting | Vaccine Therapy in Treating Patients With Metastatic Solid Tumors Condition: unspecified adult solid tumor, protocol specific |
35. | | No longer recruiting | Vaccine Therapy With or Without Sargramostim in Treating Patients With High-Risk or Metastatic Melanoma Conditions: stage III melanoma; Stage IV Melanoma; Recurrent Melanoma |
36. | | Recruiting | Zoledronate and Estradiol in Preventing Bone Loss in Patients With Prostate Cancer Conditions: Osteoporosis; stage III prostate cancer; stage IV prostate cancer |
37. | | Recruiting | Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer Conditions: Osteoporosis; stage I breast cancer; stage II breast cancer |